Yu John S - Insider Non-Derivative Transactions at Kairos Pharma, LTD. (KAPA) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Oct 8, 2025, Yu John S's relationship to Kairos Pharma, LTD. (KAPA) is Director,Officer,TenPercentOwner (CEO and Chairman), and currently has 230,105 shares of COMMON STOCK.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other KAPA insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Yu John S - Insider Non-Derivative Transactions of KAPA COMMON STOCK

Yu John S - Insider Non-Derivative Transactions at KAPA

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Oct 9, 2025	Acquisition -- (COMMON STOCK)	190840	0	230105
Jan 2, 2025	Acquisition -- (COMMON STOCK)	14000	0	5355838
Nov 21, 2024	P -- (COMMON STOCK)	4000	1.44	5341837